Clinical Trial Update: the Effect of Tracleer on Tourniquet-associated Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effect of Tracleer (bosentan) on tourniquet-associated hypertension; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Xuzhou Medical University | Conditions: Tourniquets, Hypertension | Phase 4 | Status: UNKNOWN